GSK-104297

Study Sponsor: GSK

Study Title

An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose.

Medicine or Vaccine (generic name)

RTS,S Vaccine

Sponsor Identification Number

104297

Trial Registry Identification Number(#'s)

NCT00323622

Medical Condition

Malaria

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=104297

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00323622

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 257049/026. The analysis-ready data from this study is provided in combined datasets with the analysis-ready data from 257049/026. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

July 2014